Citizens JMP raised the firm’s price target on Taysha Gene Therapies (TSHA) to $8 from $6 and keeps an Outperform rating on ...
Overall, there are 4 recent analyst reviews on file for VistaGen, and they are unanimously positive, supporting the Strong ...
Shares of Datadog came under pressure in early trading on Friday, despite the company Thursday reporting upbeat third-quarter ...
Why The Narrative Around Greystone Housing Impact Investors Is Shifting After Recent Analyst Updates
Analysts are maintaining the fair value estimate for Greystone Housing Impact Investors at $12.50. This reflects steady consensus on the company's intrinsic worth, even as the price target is adjusted ...
Microsoft, Alphabet, Meta, and Amazon are investing tens of billions in data centers. AI infrastructure is now a key driver ...
Analysts have set 12-month price targets for Affirm Holdings, revealing an average target of $92.89, a high estimate of ...
BeOne Medicines AG posts record Q3 2025 results with 41% revenue growth, BRUKINSA leadership, and major pipeline milestones.
Discover Expensify’s Q3 2025 earnings highlights, customer migration updates, and AI-driven product advancements.
The next panel explored the intersection of human expertise and artificial intelligence – how investors are learning to work with AI, turning technology into an extension of human insight.
In this Market Dialogues episode, experts discuss what’s driving efforts to connect private market data with public workflows as private markets move toward more transparency, consistent valuations, ...
This guide shows how Korea Western Power, a leading power producer in Korea with over 11,000 MW of installed capacity, ...
The challenge of open data and ubiquitous surveillance is particularly relevant in the Pacific, where Rob Christian, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results